GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 744 filers reported holding GLAXOSMITHKLINE PLC in Q3 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $738,343,000 | +2058.3% | 19,962 | +1134.5% | 0.13% | +2100.0% |
| Q3 2018 | $34,210,000 | -21.0% | 1,617 | +6.3% | 0.01% | -14.3% |
| Q2 2018 | $43,282,000 | -77.7% | 1,521 | +50.6% | 0.01% | -82.1% |
| Q1 2018 | $194,425,000 | +99.7% | 1,010 | -5.3% | 0.04% | +143.8% |
| Q4 2017 | $97,340,000 | +53977.8% | 1,066 | +11744.4% | 0.02% | – |
| Q2 2017 | $180,000 | -46.3% | 9 | -18.2% | 0.00% | – |
| Q1 2017 | $335,000 | -99.9% | 11 | -99.9% | 0.00% | -100.0% |
| Q4 2016 | $559,738,000 | +5287.8% | 12,990 | +5245.7% | 0.11% | +5400.0% |
| Q3 2016 | $10,389,000 | -98.5% | 243 | -98.6% | 0.00% | -98.2% |
| Q2 2016 | $692,571,000 | +616.2% | 17,071 | +736.8% | 0.11% | +776.9% |
| Q1 2016 | $96,695,000 | +363.9% | 2,040 | +4063.3% | 0.01% | +333.3% |
| Q4 2015 | $20,845,000 | -70.8% | 49 | -94.3% | 0.00% | -62.5% |
| Q3 2015 | $71,356,000 | +12160.5% | 866 | +1319.7% | 0.01% | – |
| Q4 2014 | $582,000 | – | 61 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
| Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
| Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
| Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
| Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
| Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
| NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
| Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
| SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
| Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |